Home › Therapeutic areas › Renal › C3 Glomerulopathy

C3 Glomerulopathy (1 companies)

Companies with an active program in C3 Glomerulopathy.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 1 Approved $111M 10